Radiopharm Theranostics Limited (AU:RAD) has released an update.
Radiopharm Theranostics Limited has witnessed a significant change in shareholding, with JPMorgan Chase & Co. and its affiliates increasing their voting power from 7.13% to 8.54% through the purchase and sale of 40,000,000 ordinary shares. The change occurred on August 27, 2024, with J.P. Morgan Securities Australia Limited executing the transactions in its capacity as Principal/Proprietary.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.
